Clinical isolates of Mycobacterium avium complex reveal an M. intracellulare-associated IL-17/neutrophilic pulmonary immune program in a murine disease model
5 affiliations
- 1Department of Pathophysiology and Host Defense, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Tokyo, Japan
- 2Department of Basic Mycobacteriosis, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
- 3Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Kiyose, Tokyo, Japan
- 4Department of Clinical Mycobacteriosis, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
- 5The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Tokyo, Japan
Abstract
Mycobacterium avium complex (MAC) is the leading cause of nontuberculous mycobacterial pulmonary disease (NTM-PD) and mainly comprises M. avium (MAV) and M. intracellulare (MI). Although MAV- and MI-associated pulmonary disease is currently treated using the same guideline-based regimens, whether MAC species and individual isolates elicit distinct pulmonary host responses remains unclear. Here, we established a panel of MAC clinical isolates exhibiting persistent pulmonary infection in mice and performed transcriptomic analyses to evaluate pulmonary immune responses. Although MAC infections induced broadly shared inflammatory responses, MI-infected lungs exhibited a robust IL-17/neutrophilic inflammatory signature, whereas MAV infection showed relative enrichment of IFN-γ-/cytotoxicity-associated responses, indicating differences in the balance of their immune gene expression programs. The MI-associated IL-17/neutrophilic program remained evident at the isolate level and after adjustment for pulmonary colony-forming unit (CFU) values. RT-qPCR and flow cytometric analyses using the representative isolate pair FKJ-1 (MI) and FKJ-8 (MAV) further supported the differential induction of these immune signatures in infected lungs. Single-cell RNA sequencing of lungs infected with FKJ-1 and FKJ-8 demonstrated that infection with the representative MI isolate was associated with increased Il17a-expressing CD4+ T cells and γδ T cells, neutrophilic inflammation, and the expansion of inflammatory macrophages. Together, these findings suggest that, within a selected panel of persistent MAC clinical isolates, MI infection is associated with a robust IL-17/neutrophilic pulmonary immune program. This study provides a preclinical framework for dissecting species- and isolate-associated host-pathogen interactions in MAC-PD.
IMPORTANCE: Mycobacterium avium complex pulmonary disease (MAC-PD) is an increasing clinical challenge with heterogeneous disease courses and outcomes. Although current guideline-based treatment does not differ between M. avium (MAV)- and M. intracellulare (MI)-associated PD, examining whether these species elicit distinct host responses may help explain heterogeneity in disease progression and clinical outcomes and support future patient stratification. We used a panel of MAC clinical isolates that persist or proliferate in mouse lungs to compare host responses induced by MAV and MI. Although both species induced broadly shared inflammation, MI infection was associated with a robust IL-17/neutrophilic program, whereas MAV infection showed relative enrichment of IFN-γ-/cytotoxicity-associated responses. The MI-associated program remained evident at the isolate level and after adjustment for pulmonary colony-forming unit (CFU) values. These findings suggest that MAC species and isolates may shape pulmonary immune landscapes, providing a preclinical framework for understanding MAC-PD heterogeneity.
Related
- COVID-19-associated pulmonary aspergillosis: clinical characteristics, species distribution, environmental fungal contamination, and antifungal susceptibility
- Nomogram models integrating multiregion radiomics, quantitative computed tomography, and clinical indicators for distinguishing connective tissue disease-associated interstitial lung disease from idiopathic pulmonary fibrosis and improving the prediction of gender-age-physiology stage
- Pneumatosis Cystoides Intestinalis Secondary to Antibiotic Therapy for Pulmonary Mycobacterium avium Complex Infection: A Case Report and Review of the Literature
- Diagnostic challenges in Mycobacterium abscessus pulmonary disease, particularly in patients with cystic fibrosis: toward an integrated precision framework
- Clinical, radiological, and pathological features of pulmonary hypertension associated with combined pulmonary fibrosis and emphysema.
BibTeX
@article{seto2026clinical,
title = {{Clinical isolates of Mycobacterium avium complex reveal an M. intracellulare-associated IL-17/neutrophilic pulmonary immune program in a murine disease model}},
author = {Shintaro Seto and Koji Furuuchi and Shiho Omori and Hajime Nakamura and Kozo Morimoto and Minako Hijikata and Naoto Keicho},
journal = {mSphere},
year = {2026},
month = sep,
doi = {10.1128/msphere.00398-26},
url = {https://doi.org/10.1128/msphere.00398-26},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Clinical isolates of Mycobacterium avium complex reveal an M. intracellulare-associated IL-17/neutrophilic pulmonary immune program in a murine disease model
AU - Shintaro Seto
AU - Koji Furuuchi
AU - Shiho Omori
AU - Hajime Nakamura
AU - Kozo Morimoto
AU - Minako Hijikata
AU - Naoto Keicho
PY - 2026
DA - 2026/09/21
JO - mSphere
DO - 10.1128/msphere.00398-26
UR - https://doi.org/10.1128/msphere.00398-26
AB - Mycobacterium avium complex (MAC) is the leading cause of nontuberculous mycobacterial pulmonary disease (NTM-PD) and mainly comprises M. avium (MAV) and M. intracellulare (MI). Although MAV- and MI-associated pulmonary disease is currently treated using the same guideline-based regimens, whether MAC species and individual isolates elicit distinct pulmonary host responses remains unclear. Here, we established a panel of MAC clinical isolates exhibiting persistent pulmonary infection in mice and performed transcriptomic analyses to evaluate pulmonary immune responses. Although MAC infections induced broadly shared inflammatory responses, MI-infected lungs exhibited a robust IL-17/neutrophilic inflammatory signature, whereas MAV infection showed relative enrichment of IFN-γ-/cytotoxicity-associated responses, indicating differences in the balance of their immune gene expression programs. The MI-associated IL-17/neutrophilic program remained evident at the isolate level and after adjustment for pulmonary colony-forming unit (CFU) values. RT-qPCR and flow cytometric analyses using the representative isolate pair FKJ-1 (MI) and FKJ-8 (MAV) further supported the differential induction of these immune signatures in infected lungs. Single-cell RNA sequencing of lungs infected with FKJ-1 and FKJ-8 demonstrated that infection with the representative MI isolate was associated with increased Il17a-expressing CD4+ T cells and γδ T cells, neutrophilic inflammation, and the expansion of inflammatory macrophages. Together, these findings suggest that, within a selected panel of persistent MAC clinical isolates, MI infection is associated with a robust IL-17/neutrophilic pulmonary immune program. This study provides a preclinical framework for dissecting species- and isolate-associated host-pathogen interactions in MAC-PD. IMPORTANCE: Mycobacterium avium complex pulmonary disease (MAC-PD) is an increasing clinical challenge with heterogeneous disease courses and outcomes. Although current guideline-based treatment does not differ between M. avium (MAV)- and M. intracellulare (MI)-associated PD, examining whether these species elicit distinct host responses may help explain heterogeneity in disease progression and clinical outcomes and support future patient stratification. We used a panel of MAC clinical isolates that persist or proliferate in mouse lungs to compare host responses induced by MAV and MI. Although both species induced broadly shared inflammation, MI infection was associated with a robust IL-17/neutrophilic program, whereas MAV infection showed relative enrichment of IFN-γ-/cytotoxicity-associated responses. The MI-associated program remained evident at the isolate level and after adjustment for pulmonary colony-forming unit (CFU) values. These findings suggest that MAC species and isolates may shape pulmonary immune landscapes, providing a preclinical framework for understanding MAC-PD heterogeneity.
SN - 2379-5042
ER -